Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease.
Détails
ID Serval
serval:BIB_B5A7E57E435B
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease.
Périodique
Sleep medicine
ISSN
1878-5506 (Electronic)
ISSN-L
1389-9457
Statut éditorial
Publié
Date de publication
09/2023
Peer-reviewed
Oui
Volume
109
Pages
1-3
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
while obstructive sleep apnea is strongly associated with incident cardiovascular diseases (CVD), the underlying mechanisms remain to be elucidated. This study aimed to compare the patterns of microRNAs expression between OSA and control patients with and without incident CVD.
218 matched adult participants with and without OSA and with and without incident CVD were selected from two independent community-based prospective cohorts in France and Switzerland, and 168 microRNAs on average were detected per sample. OSA was diagnosed using the validated Berlin questionnaire in one study (Paris Prospective Study 3) and during a full-night polysomnography in the second study (HypnoLaus Study).
there were 78 OSA patients (39 with and 39 without CVD) and 140 controls (70 with and 70 without CVD). Participants were male in 54.6% (n = 119) and mean age was 58.7 years (±9.2). Of the 183 miRNAs screened, a mean 168 assays were detected per sample, and 129 in all samples. There was no pattern of blood microRNAs expression that discriminated OSA patients with and without CVD events.
this binational study failed to find any association between a large panel of microRNAs and OSA patients with and without incident CVD.
218 matched adult participants with and without OSA and with and without incident CVD were selected from two independent community-based prospective cohorts in France and Switzerland, and 168 microRNAs on average were detected per sample. OSA was diagnosed using the validated Berlin questionnaire in one study (Paris Prospective Study 3) and during a full-night polysomnography in the second study (HypnoLaus Study).
there were 78 OSA patients (39 with and 39 without CVD) and 140 controls (70 with and 70 without CVD). Participants were male in 54.6% (n = 119) and mean age was 58.7 years (±9.2). Of the 183 miRNAs screened, a mean 168 assays were detected per sample, and 129 in all samples. There was no pattern of blood microRNAs expression that discriminated OSA patients with and without CVD events.
this binational study failed to find any association between a large panel of microRNAs and OSA patients with and without incident CVD.
Mots-clé
Cardiovascular disease, Sleep apnea, microRNA
Pubmed
Web of science
Création de la notice
29/06/2023 14:46
Dernière modification de la notice
15/08/2023 5:59